Literature DB >> 19776184

Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis.

Takahiro Kawasaki1, Kanji Igarashi, Tatsuki Koeda, Keiichiro Sugimoto, Kazuya Nakagawa, Shuichi Hayashi, Ryoichi Yamaji, Hiroshi Inui, Toshio Fukusato, Toshikazu Yamanouchi.   

Abstract

Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease are increasing in adults and are likely to be increasing in children. Both conditions are hepatic manifestations of metabolic syndrome. Experimental animals fed fructose-enriched diets are widely recognized as good models for metabolic syndrome. However, few reports have described the hepatic pathology of these experimental animals. In this study, 5-wk-old Wistar specific pathogen-free rats, which are a normal strain, were fed experimental diets for 5 wk. We then evaluated the degree of steatohepatitis. The 5 diet groups were as follows: cornstarch (70% wt:wt) [control (C)], high-fructose (70%) (HFr), high-sucrose (70%) (HS), high-fat (15%) (HF), and high-fat (15%) high-fructose (50%) (HFHFr) diets. The macrovesicular steatosis grade, liver:body weight ratio, and hepatic triglyceride concentration were significantly higher in the HFr group than in the other 4 groups. However, the HFr group had a significantly lower ratio of epididymal white fat:body weight than the other 4 groups and had a lower final body weight than the HF and HFHFr groups. The HF group had a greater final body weight than the C, HFr, and HS groups, but no macrovesicular steatosis was observed. The HFr group had a significantly higher grade of lobular inflammation than the other 4 groups. The distribution of lobular inflammation was predominant over portal inflammation, which is consistent with human NASH. In conclusion, rats fed fructose-enriched diets are a better model for NASH than rats fed fat-enriched diets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19776184     DOI: 10.3945/jn.109.105858

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  58 in total

1.  Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Kun Xiang; Christelle Johnson; Scott B Crown; Nikolai Rakhilin; Yiwei Ai; Lihua Wang; Rui Xi; Inna Astapova; Yan Han; Jiahe Li; Bradley B Barth; Min Lu; Ziyang Gao; Robert Mines; Liwen Zhang; Mark Herman; David Hsu; Guo-Fang Zhang; Xiling Shen
Journal:  Cell Metab       Date:  2018-04-26       Impact factor: 27.287

2.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH.

Authors:  Takahiro Tsuchiya; Takeshi Naitoh; Munenori Nagao; Naoki Tanaka; Kazuhiro Watanabe; Hirofumi Imoto; Tomohiro Miyachi; Fuyuhiko Motoi; Michiaki Unno
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

4.  Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats.

Authors:  Ana Vasiljević; Biljana Bursać; Ana Djordjevic; Danijela Vojnović Milutinović; Marina Nikolić; Gordana Matić; Nataša Veličković
Journal:  Eur J Nutr       Date:  2014-01-04       Impact factor: 5.614

Review 5.  Hepatic expression and cellular distribution of the glucose transporter family.

Authors:  Sumera Karim; David H Adams; Patricia F Lalor
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

6.  Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004.

Authors:  Krista L Yorita Christensen; Caroline K Carrico; Arun J Sanyal; Chris Gennings
Journal:  Int J Hyg Environ Health       Date:  2013-03-09       Impact factor: 5.840

Review 7.  Implications of diet on nonalcoholic fatty liver disease.

Authors:  Shelby Sullivan
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

Review 8.  Fructose and cardiometabolic disorders: the controversy will, and must, continue.

Authors:  Nicolas Wiernsperger; Alain Geloen; Jean-Robert Rapin
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

9.  Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model.

Authors:  Atsunori Nabeshima; Sohsuke Yamada; Xin Guo; Akihide Tanimoto; Ke-Yong Wang; Shohei Shimajiri; Satoshi Kimura; Takashi Tasaki; Hirotsugu Noguchi; Shohei Kitada; Teruo Watanabe; Junichi Fujii; Kimitoshi Kohno; Yasuyuki Sasaguri
Journal:  Antioxid Redox Signal       Date:  2013-05-03       Impact factor: 8.401

Review 10.  Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

Authors:  Natalia Rosso; Norberto C Chavez-Tapia; Claudio Tiribelli; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.